de Lope Quiñones, S.; Luque-Ramírez, M.; Michael Fernández, A.C.; Quintero Tobar, A.; Quiñones-Silva, J.; Martínez García, M.Á.; Insenser Nieto, M.; Dorado Avendaño, B.; Escobar-Morreale, H.F.; Nattero-Chávez, L.
Unveiling Silent Atherosclerosis in Type 1 Diabetes: The Role of Glycoprotein and Lipoprotein Lipidomics, and Cardiac Autonomic Neuropathy. Metabolites 2025, 15, 55.
https://doi.org/10.3390/metabo15010055
AMA Style
de Lope Quiñones S, Luque-Ramírez M, Michael Fernández AC, Quintero Tobar A, Quiñones-Silva J, Martínez García MÁ, Insenser Nieto M, Dorado Avendaño B, Escobar-Morreale HF, Nattero-Chávez L.
Unveiling Silent Atherosclerosis in Type 1 Diabetes: The Role of Glycoprotein and Lipoprotein Lipidomics, and Cardiac Autonomic Neuropathy. Metabolites. 2025; 15(1):55.
https://doi.org/10.3390/metabo15010055
Chicago/Turabian Style
de Lope Quiñones, Sara, Manuel Luque-Ramírez, Antonio Carlos Michael Fernández, Alejandra Quintero Tobar, Jhonatan Quiñones-Silva, María Ángeles Martínez García, María Insenser Nieto, Beatriz Dorado Avendaño, Héctor F. Escobar-Morreale, and Lía Nattero-Chávez.
2025. "Unveiling Silent Atherosclerosis in Type 1 Diabetes: The Role of Glycoprotein and Lipoprotein Lipidomics, and Cardiac Autonomic Neuropathy" Metabolites 15, no. 1: 55.
https://doi.org/10.3390/metabo15010055
APA Style
de Lope Quiñones, S., Luque-Ramírez, M., Michael Fernández, A. C., Quintero Tobar, A., Quiñones-Silva, J., Martínez García, M. Á., Insenser Nieto, M., Dorado Avendaño, B., Escobar-Morreale, H. F., & Nattero-Chávez, L.
(2025). Unveiling Silent Atherosclerosis in Type 1 Diabetes: The Role of Glycoprotein and Lipoprotein Lipidomics, and Cardiac Autonomic Neuropathy. Metabolites, 15(1), 55.
https://doi.org/10.3390/metabo15010055
